Therapy of Advanced Established Murine Breast Cancer With a Recombinant Adenoviral ErbB-2/neu Vaccine

Cancer Research - United States
doi 10.1158/0008-5472.can-07-5688
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

ErbB-2/Her2/neu Overexpression and Estrogen-Dependency in Breast Carcinogenesis

2005English

ErbB-2 Nuclear Function in Breast Cancer Growth, Metastasis and Resistance to Therapy

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

Recombinant Vaccine Strategies for Breast Cancer Prevention

1999English

Genetic Prodrug Activation in erbB-2 Overexpressing Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
1999English

Antiangiogenic Cancer Therapy Using Peptide Vaccine for Patients With Advanced Pancreatic Cancer

Suizo
2010English

Adenoviral Vector Expressing Murine Β-Defensin 2 Enhances Immunogenicity of an Adenoviral Vector Based H5N1 Influenza Vaccine in Aged Mice

Virus Research
Cancer ResearchVirologyInfectious Diseases
2013English

Humoral Epitope-Spreading Following Immunization With a HER-2/neu Peptide Based Vaccine in Cancer Patients

Journal of Clinical Immunology
AllergyImmunology
2004English

Complete Pathological Response in Patients With Locally Advanced Cancer of Breast and Positive Her2/Neu With Neoadjuvant Chemotherapy

BMC Cancer
Cancer ResearchOncologyGenetics
2007English

Hormone Receptors, Her-2/Neu and Chromosomal Aberrations in Breast Cancer

Medical Journal Armed Forces India
Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy